LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Type III interferons disrupt the lung epithelial barrier upon viral recognition.

    Broggi, Achille / Ghosh, Sreya / Sposito, Benedetta / Spreafico, Roberto / Balzarini, Fabio / Lo Cascio, Antonino / Clementi, Nicola / De Santis, Maria / Mancini, Nicasio / Granucci, Francesca / Zanoni, Ivan

    Science (New York, N.Y.)

    2020  Volume 369, Issue 6504, Page(s) 706–712

    Abstract: Viral infections of the lower respiratory tract are a leading cause of mortality. Mounting evidence indicates that most severe cases are characterized by aberrant immune responses and do not depend on viral burden. In this study, we assessed how type III ...

    Abstract Viral infections of the lower respiratory tract are a leading cause of mortality. Mounting evidence indicates that most severe cases are characterized by aberrant immune responses and do not depend on viral burden. In this study, we assessed how type III interferons (IFN-λ) contribute to the pathogenesis induced by RNA viruses. We report that IFN-λ is present in the lower, but not upper, airways of patients with coronavirus disease 2019 (COVID-19). In mice, we demonstrate that IFN-λ produced by lung dendritic cells in response to a synthetic viral RNA induces barrier damage, causing susceptibility to lethal bacterial superinfections. These findings provide a strong rationale for rethinking the pathophysiological role of IFN-λ and its possible use in clinical practice against endemic viruses, such as influenza virus as well as the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
    MeSH term(s) Animals ; Betacoronavirus ; Bronchoalveolar Lavage Fluid/immunology ; COVID-19 ; Cell Proliferation ; Coronavirus Infections/immunology ; Coronavirus Infections/metabolism ; Cytokines/metabolism ; Dendritic Cells/metabolism ; Humans ; Interferon Type I/metabolism ; Interferons/metabolism ; Interferons/physiology ; Lung/immunology ; Lung/metabolism ; Lung/pathology ; Mice ; Mice, Inbred C57BL ; Nasopharynx/immunology ; Pandemics ; Pneumonia, Viral/immunology ; Pneumonia, Viral/metabolism ; Poly I-C/administration & dosage ; Respiratory Mucosa/pathology ; SARS-CoV-2 ; Signal Transduction ; Staphylococcal Infections/metabolism ; Superinfection ; Toll-Like Receptor 3/metabolism
    Chemical Substances Cytokines ; Interferon Type I ; TLR3 protein, mouse ; Toll-Like Receptor 3 ; interferon type III ; Interferons (9008-11-1) ; Poly I-C (O84C90HH2L)
    Keywords covid19
    Language English
    Publishing date 2020-06-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.abc3545
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Crystal structure of U2 snRNP SF3b components: Hsh49p in complex with Cus1p-binding domain.

    van Roon, Anne-Marie M / Oubridge, Chris / Obayashi, Eiji / Sposito, Benedetta / Newman, Andrew J / Séraphin, Bertrand / Nagai, Kiyoshi

    RNA (New York, N.Y.)

    2017  Volume 23, Issue 6, Page(s) 968–981

    Abstract: Spliceosomal proteins Hsh49p and Cus1p are components of SF3b, which together with SF3a, Msl1p/Lea1p, Sm proteins, and U2 snRNA, form U2 snRNP, which plays a crucial role in pre-mRNA splicing. Hsh49p, comprising two RRMs, forms a heterodimer with Cus1p. ... ...

    Abstract Spliceosomal proteins Hsh49p and Cus1p are components of SF3b, which together with SF3a, Msl1p/Lea1p, Sm proteins, and U2 snRNA, form U2 snRNP, which plays a crucial role in pre-mRNA splicing. Hsh49p, comprising two RRMs, forms a heterodimer with Cus1p. We determined the crystal structures of
    MeSH term(s) Amino Acid Sequence ; Binding Sites ; Conserved Sequence ; Models, Molecular ; Multiprotein Complexes/metabolism ; Proline-Rich Protein Domains ; Protein Binding ; Protein Conformation ; Protein Interaction Domains and Motifs ; RNA/chemistry ; RNA/genetics ; RNA/metabolism ; RNA, Small Nuclear/chemistry ; RNA, Small Nuclear/genetics ; RNA, Small Nuclear/metabolism ; RNA-Binding Proteins/chemistry ; RNA-Binding Proteins/metabolism ; Ribonucleoprotein, U2 Small Nuclear/chemistry ; Ribonucleoprotein, U2 Small Nuclear/metabolism
    Chemical Substances Multiprotein Complexes ; RNA, Small Nuclear ; RNA-Binding Proteins ; Ribonucleoprotein, U2 Small Nuclear ; U2 small nuclear RNA ; RNA (63231-63-0)
    Language English
    Publishing date 2017-03-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1241540-6
    ISSN 1469-9001 ; 1355-8382
    ISSN (online) 1469-9001
    ISSN 1355-8382
    DOI 10.1261/rna.059378.116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients.

    Sposito, Benedetta / Broggi, Achille / Pandolfi, Laura / Crotta, Stefania / Ferrarese, Roberto / Sisti, Sofia / Clementi, Nicola / Ambrosi, Alessandro / Liu, Enju / Frangipane, Vanessa / Saracino, Laura / Marongiu, Laura / Facchini, Fabio A / Bottazzi, Andrea / Fossali, Tommaso / Colombo, Riccardo / Clementi, Massimo / Tagliabue, Elena / Pontiroli, Antonio E /
    Meloni, Federica / Wack, Andreas / Mancini, Nicasio / Zanoni, Ivan

    bioRxiv : the preprint server for biology

    2021  

    Abstract: The COVID-19 outbreak driven by SARS-CoV-2 has caused more than 2.5 million deaths globally, with the most severe cases characterized by over-exuberant production of immune-mediators, the nature of which is not fully understood. Interferons of the type I ...

    Abstract The COVID-19 outbreak driven by SARS-CoV-2 has caused more than 2.5 million deaths globally, with the most severe cases characterized by over-exuberant production of immune-mediators, the nature of which is not fully understood. Interferons of the type I (IFN-I) or type III (IFN-III) families are potent antivirals, but their role in COVID-19 remains debated. Our analysis of gene and protein expression along the respiratory tract shows that IFNs, especially IFN-III, are over-represented in the lower airways of patients with severe COVID-19, while high levels of IFN-III, and to a lesser extent IFN-I, characterize the upper airways of patients with high viral burden but reduced disease risk or severity; also, IFN expression varies with abundance of the cell types that produce them. Our data point to a dynamic process of inter- and intra-family production of IFNs in COVID-19, and suggest that IFNs play opposing roles at distinct anatomical sites.
    Language English
    Publishing date 2021-03-30
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2021.03.30.437173
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The interferon landscape along the respiratory tract impacts the severity of COVID-19

    Sposito, Benedetta / Broggi, Achille / Pandolfi, Laura / Crotta, Stefania / Clementi, Nicola / Ferrarese, Roberto / Sisti, Sofia / Criscuolo, Elena / Spreafico, Roberto / Long, Jaclyn M. / Ambrosi, Alessandro / Liu, Enju / Frangipane, Vanessa / Saracino, Laura / Bozzini, Sara / Marongiu, Laura / Facchini, Fabio A. / Bottazzi, Andrea / Fossali, Tommaso /
    Colombo, Riccardo / Clementi, Massimo / Tagliabue, Elena / Chou, Janet / Pontiroli, Antonio E. / Meloni, Federica / Wack, Andreas / Mancini, Nicasio / Zanoni, Ivan

    Cell. 2021 Sept. 16, v. 184, no. 19

    2021  

    Abstract: Severe coronavirus disease 2019 (COVID-19) is characterized by overproduction of immune mediators, but the role of interferons (IFNs) of the type I (IFN-I) or type III (IFN-III) families remains debated. We scrutinized the production of IFNs along the ... ...

    Abstract Severe coronavirus disease 2019 (COVID-19) is characterized by overproduction of immune mediators, but the role of interferons (IFNs) of the type I (IFN-I) or type III (IFN-III) families remains debated. We scrutinized the production of IFNs along the respiratory tract of COVID-19 patients and found that high levels of IFN-III, and to a lesser extent IFN-I, characterize the upper airways of patients with high viral burden but reduced disease risk or severity. Production of specific IFN-III, but not IFN-I, members denotes patients with a mild pathology and efficiently drives the transcription of genes that protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In contrast, compared to subjects with other infectious or noninfectious lung pathologies, IFNs are overrepresented in the lower airways of patients with severe COVID-19 that exhibit gene pathways associated with increased apoptosis and decreased proliferation. Our data demonstrate a dynamic production of IFNs in SARS-CoV-2-infected patients and show IFNs play opposing roles at distinct anatomical sites.
    Keywords COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; apoptosis ; genes ; interferons ; landscapes ; lungs ; risk ; viral load
    Language English
    Dates of publication 2021-0916
    Size p. 4953-4968.e16.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2021.08.016
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: Type III interferons disrupt the lung epithelial barrier upon viral recognition

    Broggi, Achille / Ghosh, Sreya / Sposito, Benedetta / Spreafico, Roberto / Balzarini, Fabio / Lo Cascio, Antonino / Clementi, Nicola / De Santis, Maria / Mancini, Nicasio / Granucci, Francesca / Zanoni, Ivan

    Science

    Abstract: Viral infections of the lower respiratory tract are a leading cause of mortality. Mounting evidence indicates that most severe cases are characterized by aberrant immune responses and do not depend on viral burden. In this study, we assessed how type III ...

    Abstract Viral infections of the lower respiratory tract are a leading cause of mortality. Mounting evidence indicates that most severe cases are characterized by aberrant immune responses and do not depend on viral burden. In this study, we assessed how type III interferons (IFN-λ) contribute to the pathogenesis induced by RNA viruses. We report that IFN-λ is present in the lower, but not upper, airways of patients with coronavirus disease 2019 (COVID-19). In mice, we demonstrate that IFN-λ produced by lung dendritic cells in response to a synthetic viral RNA induces barrier damage, causing susceptibility to lethal bacterial superinfections. These findings provide a strong rationale for rethinking the pathophysiological role of IFN-λ and its possible use in clinical practice against endemic viruses, such as influenza virus as well as the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #717344
    Database COVID19

    Kategorien

  6. Article ; Online: Type III interferons disrupt the lung epithelial barrier upon viral recognition

    Broggi, Achille / Ghosh, Sreya / Sposito, Benedetta / Spreafico, Roberto / Balzarini, Fabio / Lo Cascio, Antonino / Clementi, Nicola / De Santis, Maria / Mancini, Nicasio / Granucci, Francesca / Zanoni, Ivan

    Science

    2020  Volume 369, Issue 6504, Page(s) 706–712

    Abstract: Viral infections of the lower respiratory tract are a leading cause of mortality. Mounting evidence indicates that most severe cases are characterized by aberrant immune responses and do not depend on viral burden. In this study, we assessed how type III ...

    Abstract Viral infections of the lower respiratory tract are a leading cause of mortality. Mounting evidence indicates that most severe cases are characterized by aberrant immune responses and do not depend on viral burden. In this study, we assessed how type III interferons (IFN-λ) contribute to the pathogenesis induced by RNA viruses. We report that IFN-λ is present in the lower, but not upper, airways of patients with coronavirus disease 2019 (COVID-19). In mice, we demonstrate that IFN-λ produced by lung dendritic cells in response to a synthetic viral RNA induces barrier damage, causing susceptibility to lethal bacterial superinfections. These findings provide a strong rationale for rethinking the pathophysiological role of IFN-λ and its possible use in clinical practice against endemic viruses, such as influenza virus as well as the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
    Keywords Multidisciplinary ; covid19
    Language English
    Publisher American Association for the Advancement of Science (AAAS)
    Publishing country us
    Document type Article ; Online
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.abc3545
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: The interferon landscape along the respiratory tract impacts the severity of COVID-19.

    Sposito, Benedetta / Broggi, Achille / Pandolfi, Laura / Crotta, Stefania / Clementi, Nicola / Ferrarese, Roberto / Sisti, Sofia / Criscuolo, Elena / Spreafico, Roberto / Long, Jaclyn M / Ambrosi, Alessandro / Liu, Enju / Frangipane, Vanessa / Saracino, Laura / Bozzini, Sara / Marongiu, Laura / Facchini, Fabio A / Bottazzi, Andrea / Fossali, Tommaso /
    Colombo, Riccardo / Clementi, Massimo / Tagliabue, Elena / Chou, Janet / Pontiroli, Antonio E / Meloni, Federica / Wack, Andreas / Mancini, Nicasio / Zanoni, Ivan

    Cell

    2021  Volume 184, Issue 19, Page(s) 4953–4968.e16

    Abstract: Severe coronavirus disease 2019 (COVID-19) is characterized by overproduction of immune mediators, but the role of interferons (IFNs) of the type I (IFN-I) or type III (IFN-III) families remains debated. We scrutinized the production of IFNs along the ... ...

    Abstract Severe coronavirus disease 2019 (COVID-19) is characterized by overproduction of immune mediators, but the role of interferons (IFNs) of the type I (IFN-I) or type III (IFN-III) families remains debated. We scrutinized the production of IFNs along the respiratory tract of COVID-19 patients and found that high levels of IFN-III, and to a lesser extent IFN-I, characterize the upper airways of patients with high viral burden but reduced disease risk or severity. Production of specific IFN-III, but not IFN-I, members denotes patients with a mild pathology and efficiently drives the transcription of genes that protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In contrast, compared to subjects with other infectious or noninfectious lung pathologies, IFNs are overrepresented in the lower airways of patients with severe COVID-19 that exhibit gene pathways associated with increased apoptosis and decreased proliferation. Our data demonstrate a dynamic production of IFNs in SARS-CoV-2-infected patients and show IFNs play opposing roles at distinct anatomical sites.
    MeSH term(s) Age Factors ; Aging/pathology ; COVID-19/genetics ; COVID-19/immunology ; COVID-19/pathology ; Epithelial Cells/pathology ; Epithelial Cells/virology ; Gene Expression Regulation ; Humans ; Interferons/genetics ; Interferons/metabolism ; Leukocytes/pathology ; Leukocytes/virology ; Lung/pathology ; Lung/virology ; Respiratory Distress Syndrome/pathology ; Respiratory Distress Syndrome/virology ; Respiratory System/virology ; Severity of Illness Index ; Viral Load
    Chemical Substances Interferons (9008-11-1)
    Language English
    Publishing date 2021-08-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2021.08.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients.

    Sposito, Benedetta / Broggi, Achille / Pandolfi, Laura / Crotta, Stefania / Ferrarese, Roberto / Sisti, Sofia / Clementi, Nicola / Ambrosi, Alessandro / Liu, Enju / Frangipane, Vanessa / Saracino, Laura / Marongiu, Laura / Facchini, Fabio / Bottazzi, Andrea / Fossali, Tomaso / Colombo, Riccardo / Clementi, Massimo / Tagliabue, Elena / Pontiroli, Antonio /
    Meloni, Federica / Wack, Andreas / Mancini, Nicasio / Zanoni, Ivan

    bioRxiv

    Abstract: The COVID-19 outbreak driven by SARS-CoV-2 has caused more than 2.5 million deaths globally, with the most severe cases characterized by over-exuberant production of immune-mediators, the nature of which is not fully understood. Interferons of the type I ...

    Abstract The COVID-19 outbreak driven by SARS-CoV-2 has caused more than 2.5 million deaths globally, with the most severe cases characterized by over-exuberant production of immune-mediators, the nature of which is not fully understood. Interferons of the type I (IFN-I) or type III (IFN-III) families are potent antivirals, but their role in COVID-19 remains debated. Our analysis of gene and protein expression along the respiratory tract shows that IFNs, especially IFN-III, are over-represented in the lower airways of patients with severe COVID-19, while high levels of IFN-III, and to a lesser extent IFN-I, characterize the upper airways of patients with high viral burden but reduced disease risk or severity; also, IFN expression varies with abundance of the cell types that produce them. Our data point to a dynamic process of inter- and intra-family production of IFNs in COVID-19, and suggest that IFNs play opposing roles at distinct anatomical sites.
    Keywords covid19
    Language English
    Publishing date 2021-03-30
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.03.30.437173
    Database COVID19

    Kategorien

To top